Health Canada · Canada

Health Canada Digital Therapeutics Advertising

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.

Food and Drugs Act ss. 3, 20, Sch. A.1; Medical Devices Regulations s. 27

What is Health Canada Digital Therapeutics Advertising?

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed. Consumer and app-store marketing in Canada for health apps, digital therapeutics and software medical

International

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, patients, customers · Medical Device, Telehealth · healthcare

Where does this rule apply?

Canada

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.

How can marketing teams comply?

Consumer and app-store marketing in Canada for health apps, digital therapeutics and software medical devices that make medical claims.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
Health Canada
Jurisdiction
Canada
Official citation
Food and Drugs Act ss. 3, 20, Sch. A.1; Medical Devices Regulations s. 27
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
Medical Device, Telehealth
Audiences
general_audience, general_adults_18plus, patients, customers

Frequently asked questions

What is Health Canada Digital Therapeutics Advertising?

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.

Who does this rule apply to?

general_audience, general_adults_18plus, patients, customers · Medical Device, Telehealth · healthcare

Where does this rule apply?

Canada

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan